GREGORY MESA: Open Payments
NPI 1023144193 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,534 in 124 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,534
Food & beverage: $2,534
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $605 |
| ABBVIE INC. | 19 | $377 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $292 |
| Amgen Inc. | 10 | $161 |
| Lilly USA, LLC | 9 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $136 |
| Astellas Pharma US Inc | 6 | $132 |
| PFIZER INC. | 6 | $120 |
| Lundbeck LLC | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
Products named: Kerendia, FARXIGA, BREZTRI, REXULTI, VRAYLAR, MOUNJARO, CAPLYTA, Veozah.
Industry payments across SC — which companies pay providers there.
